Evidence map›Paper›PMID 26097778›Full record

ArticleKidney international supplements2015

United States Renal Data System public health surveillance of chronic kidney disease and end-stage renal disease.

Allan J Collins, Robert N Foley, David T Gilbertson, Shu-Cheng Chen

3 registry-linked trialsOpen access · bronzeAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Kidney international supplements, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to 3 registered trials, which are not on this map. Cited by 175 papers, 7 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
175citing papers in PubMed, 7 pooled it
22.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT03666208 phase2completednot on this mapstarted 2018, after this paper: background citation

Sirolimus Coated Angioplasty Balloon in the Salvage of Thrombosed Arteriovenous Graft

TypeinterventionalSponsorSingapore General HospitalRan2018 to 2019Enrolled20ConditionsEnd Stage Renal Failure on Dialysis, Arteriovenous Graft OcclusionArmsSirolimus Coated Balloon
NCT03923933 phase2completednot on this mapstarted 2019, after this paper: background citation

Chlortalidone and Bumetanide in Advanced Chronic Kidney Disease: HEBE-CKD Trial

TypeinterventionalSponsorHospital General de México Dr. Eduardo LiceagaRan2019 to 2019Enrolled34ConditionsRenal Insufficiency, ChronicArmsChlorthalidone, Bumetanide
NCT05316038 unknown statusnot on this mapstarted 2022, after this paper: background citation

Study of the Impact of Belatacept Conversion on Metabolic and Infectious Complications in Kidney Transplant Recipients at Grenoble-Alpes University Hospital

TypeobservationalSponsorUniversity Hospital, GrenobleRan2022 to 2024Enrolled100ConditionsKidney Transplant Infection, Cardiovascular Diseases, Immunosuppression, Kidney TransplantArmsOral glucose tolerance test
3 · Its place in the literature

Who cites it

175 citing papers in PubMed, 7 syntheses or guidelines pooled it, 447 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. [Robot-assisted kidney transplantation].Der Urologe. Ausg. A · 2020
    Pooled it
  4. Pooled it
  5. Pooled it
  6. Pooled it
  7. Pooled it
  8. Trial
  9. Trial
  10. Trial
  11. Trial
  12. Trial
  13. Trial
  14. Observational
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article

115 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Allan J CollinsChronic Disease Research Group, Minneapolis Medical Research Foundation , Minneapolis, Minnesota, USA ; Department of Medicine, University of Minnesota , Minneapolis, Minnesota, USA.
Robert N FoleyChronic Disease Research Group, Minneapolis Medical Research Foundation , Minneapolis, Minnesota, USA ; Department of Medicine, University of Minnesota , Minneapolis, Minnesota, USA.
David T GilbertsonChronic Disease Research Group, Minneapolis Medical Research Foundation , Minneapolis, Minnesota, USA.
Shu-Cheng ChenChronic Disease Research Group, Minneapolis Medical Research Foundation , Minneapolis, Minnesota, USA.
Orthopaedic Research Foundation · USUniversity of Minnesota · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The United States Renal Data System (USRDS) began in 1989 through US Congressional authorization under National Institutes of Health competitive contracting. Its history includes five contract periods, two of 5 years, two of 7.5 years, and the fifth, awarded in February 2014, of 5 years. Over these 25 years, USRDS reporting transitioned from basic incidence and prevalence of end-stage renal disease (ESRD), modalities, and overall survival, as well as focused special studies on dialysis, in the first two contract periods to a comprehensive assessment of aspects of care that affect morbidity and mortality in the second two periods. Beginning in 1999, the Minneapolis Medical Research Foundation investigative team transformed the USRDS into a total care reporting system including disease severity, hospitalizations, pediatric populations, prescription drug use, and chronic kidney disease and the transition to ESRD. Areas of focus included issues related to death rates in the first 4 months of treatment, sudden cardiac death, ischemic and valvular heart disease, congestive heart failure, atrial fibrillation, and infectious complications (particularly related to dialysis catheters) in hemodialysis and peritoneal dialysis patients; the burden of congestive heart failure and infectious complications in pediatric dialysis and transplant populations; and morbidity and access to care. The team documented a plateau and decline in incidence rates, a 28% decline in death rates since 2001, and changes under the 2011 Prospective Payment System with expanded bundled payments for each dialysis treatment. The team reported on Bayesian methods to calculate mortality ratios, which reduce the challenges of traditional methods, and introduced objectives under the Health People 2010 and 2020 national health care goals for kidney disease.

Indexed as

end-stage renal diseasepublic healthsurveillanceUnited States Renal Data System

Identifiers

PMID26097778
PMCPMC4455192
OpenAlexW2113286783

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.